Zoetis Stock Hits Day Low of $85.33 Amid Price Pressure

Zoetis, Inc., a prominent player in the Pharmaceuticals & Biotechnology sector, has experienced significant volatility today, with the stock hitting an intraday low of USD 85.33. This decline is part of a broader trend, as the stock has recorded a substantial loss of 21.5% for the day, contrasting sharply with the S&P 500's modest decline of 0.38%. Over the past week, Zoetis has seen a decrease of 24.06%, and its performance over the last month has dropped by 25.25%. Year-to-date, the stock is down 30.61%, and it has faced a staggering 44.03% decline over the past year. In a longer-term view, the stock has underperformed significantly, with a 53.12% drop over the last three years. Despite these challenges, Zoetis maintains a strong financial position, highlighted by a high return on capital employed (ROCE) of 33.61% and a low debt-to-EBITDA ratio of 1.22 times. The company has also shown resilience with consistent positive results over the last six quarters, indicating a solid operational foundation amidst current market pressures.